Pilot trial of an evidence-based low intensity psychosocial intervention delivered by lay therapists for asylum seekers and refugees

Pilot trial of an evidence-based low-intensity psychosocial intervention (Problem Management Plus) delivered by lay therapists for asylum seekers and refugees

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN15214107

Enrollment

105

Registered

2019-09-10

Start date

2019-11-27

Completion date

Unknown

Last updated

2023-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental health Mental and Behavioural Disorders

Interventions

(iii) Get Going, Keep Doing (applying behavioural activation techniques)

Participants will be randomised in the ratio 1:1:1 to one of three arms: Individual Problem Management Plus (PM+), Group Problem Management Plus (PM+) or no PM+ (control arm - participants will recei

(ii) Managing Problems (using problem-solving techniques)

and (iv) Strengthening Social Support. These strategies are applied by participants during the intervention session to problems they are facing. Each strategy is reviewed in subsequent sessions, with

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Asylum seekers and refugees 2. Age =18 years (self-reported) 3. Score of =8 on either the depression or anxiety subscale of HADS and score of =17 on WHODAS 4. Good working knowledge of one or more of English, Farsi, Urdu and Arabic 5. Registered with a GP in Liverpool City Region 6. Willing to provide relevant socioeconomic data (age, medical information etc) 7. Provided written informed consent

Exclusion criteria

Exclusion criteria: 1. New arrivals to the UK (<28 days) 2. In Initial Accommodation and receiving Section 98 support for <28 days, due to high likelihood of dispersal outside the region 3. Imminent risk of suicide 4. Complex mental disorder (bipolar disorder/manic depression, or schizophrenia) 5. Cognitive impairment (moderate/severe intellectual disability, any dementia) 6. Substance misuse 7. Currently receiving a formal psychological therapy

Design outcomes

Primary

Measure	Time frame
Severity of combined anxiety and depressive symptoms measured using Hospital Anxiety and Depression Scale (HADS) at 13 weeks post-baseline	—

Secondary

Measure	Time frame
1. Severity of combined anxiety and depressive symptoms measured using HADS.at 26 weeks post-baseline 2. Subjective wellbeing measured using WHO-5 at 13- and 26-weeks post-baseline 3. Functional impairment measured using WHODAS 2.0 at 13- and 26-weeks post-baseline 4. Progress on problems for which participant has sought help, measured using PSYCHLOPS at 13- and 26-weeks post-baseline 5. Post-traumatic stress disorder measured using PCL-5 at 13- and 26-weeks post-baseline 6. Depressive disorder measured using PHQ-9 at 13- and 26-weeks post-baseline 7. Service and support use measured using CSRI at 13- and 26-weeks post-baseline	—

Measure

Time frame

1. Severity of combined anxiety and depressive symptoms measured using HADS.at 26 weeks post-baseline 2. Subjective wellbeing measured using WHO-5 at 13- and 26-weeks post-baseline 3. Functional impairment measured using WHODAS 2.0 at 13- and 26-weeks post-baseline 4. Progress on problems for which participant has sought help, measured using PSYCHLOPS at 13- and 26-weeks post-baseline 5. Post-traumatic stress disorder measured using PCL-5 at 13- and 26-weeks post-baseline 6. Depressive disorder measured using PHQ-9 at 13- and 26-weeks post-baseline 7. Service and support use measured using CSRI at 13- and 26-weeks post-baseline

—

Countries

England, United Kingdom

Contacts

Public ContactBecky Rawlinson

prosper.study@liverpool.ac.uk+44 (0)151 795 8782

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 18, 2026